These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 23514246)

  • 1. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial.
    Nichols AC; Yoo J; Hammond JA; Fung K; Winquist E; Read N; Venkatesan V; MacNeil SD; Ernst DS; Kuruvilla S; Chen J; Corsten M; Odell M; Eapen L; Theurer J; Doyle PC; Wehrli B; Kwan K; Palma DA
    BMC Cancer; 2013 Mar; 13():133. PubMed ID: 23514246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.
    Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
    J Clin Oncol; 2022 Mar; 40(8):866-875. PubMed ID: 34995124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
    Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
    Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC).
    Bußmann L; Laban S; Wittekindt C; Stromberger C; Tribius S; Möckelmann N; Böttcher A; Betz CS; Klussmann JP; Budach V; Muenscher A; Busch CJ
    BMC Cancer; 2020 Jul; 20(1):701. PubMed ID: 32727416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life outcomes comparing primary Transoral Robotic Surgery (TORS) with primary radiotherapy for early-stage oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis.
    Gupta KK; De M; Athanasiou T; Georgalas C; Garas G
    Eur J Surg Oncol; 2024 Jul; 50(7):108434. PubMed ID: 38795678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
    Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
    Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Descriptive Study of Quality of Life Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Diaconescu A; Silver JA; Subramaniam T; Sewitch MJ; Mascarella MA; Ramirez-Garcia Luna J; Golabi N; Richardson K; Bouganim N; Forghani R; Marcin Mlynarek A; Hier MP; Sadeghi N
    J Otolaryngol Head Neck Surg; 2024; 53():19160216241248670. PubMed ID: 38888957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial.
    Weinstein GS; Quon H; O'Malley BW; Kim GG; Cohen MA
    Laryngoscope; 2010 Sep; 120(9):1749-55. PubMed ID: 20717944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of Life After Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer.
    Silver JA; Bouganim N; Richardson K; Henry M; Mascarella MA; Ramirez-GarciaLuna J; Golabi N; Mlynarek AM; Zeitouni A; Hier MP; Caglar D; Esfahani K; Sadeghi N
    JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):65-74. PubMed ID: 38060238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial.
    de Almeida JR; Martino R; Hosni A; Goldstein DP; Bratman SV; Chepeha DB; Waldron JN; Weinreb I; Perez-Ordonez B; Yu E; Metser U; Hansen AR; Xu W; Su SJ; Kim J
    JAMA Otolaryngol Head Neck Surg; 2024 Jun; 150(6):463-471. PubMed ID: 38602692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making a case for high-volume robotic surgery centers: A cost-effectiveness analysis of transoral robotic surgery.
    Rudmik L; An W; Livingstone D; Matthews W; Seikaly H; Scrimger R; Marshall D
    J Surg Oncol; 2015 Aug; 112(2):155-63. PubMed ID: 26171771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Hughes RT; Levine BJ; May N; Shenker RF; Yang JH; Lanier CM; Frizzell BA; Greven KM; Waltonen JD
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(5):284-293. PubMed ID: 37647863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.
    Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U
    Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
    Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.
    Swisher-McClure S; Lukens JN; Aggarwal C; Ahn P; Basu D; Bauml JM; Brody R; Chalian A; Cohen RB; Fotouhi-Ghiam A; Geiger G; Gershowitz J; Livolsi V; Mitra N; Montone K; Newman J; Ojerholm E; O'Malley B; Rajasekaran K; Tan E; Weinstein G; Lin A
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):725-732. PubMed ID: 31785337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of oropharyngeal squamous cell carcinoma: Is swallowing quality better after TORS or RT?
    Campo F; Iocca O; De Virgilio A; Mazzola F; Mercante G; Pichi B; Holsinger FC; Di Maio P; Ramella S; Pellini R
    Radiother Oncol; 2023 Jun; 183():109547. PubMed ID: 36813176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer.
    Zebolsky AL; George E; Gulati A; Wai KC; Carpenter P; Van Zante A; Ha PK; Heaton CM; Ryan WR
    JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1080-1088. PubMed ID: 34673904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.
    Nichols AC; Lang P; Prisman E; Berthelet E; Tran E; Hamilton S; Wu J; Fung K; de Almeida JR; Bayley A; Goldstein DP; Eskander A; Husain Z; Bahig H; Christopoulous A; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Mendez A; Winquist E; Read N; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Corsten M; Rajaraman M; Johnson-Obaseki S; Eapen L; Odell M; Chandarana S; Banerjee R; Dort J; Matthews TW; Hart R; Kerr P; Dowthwaite S; Gupta M; Zhang H; Wright J; Parker C; Wehrli B; Kwan K; Theurer J; Palma DA
    BMC Cancer; 2020 Feb; 20(1):125. PubMed ID: 32059705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinoma.
    Park YM; Kim HR; Cho BC; Keum KC; Cho NH; Kim SH
    Oral Oncol; 2017 Dec; 75():16-21. PubMed ID: 29224814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.